A 2026 study in Nature Metabolism found that a gene called KDM6B helps keep immune cells in fat tissue in a state that supports healthy fat growth. According to research reviewed by Gram, mice lacking this gene developed swollen fat cells, inflammation, and poorer blood sugar control. The findings are early and come mainly from animal experiments.

Fat tissue needs to be able to grow and store energy safely. Gram Research analysis of a 2026 study in Nature Metabolism found that a gene called KDM6B helps keep certain immune cells, called macrophages, working in a way that supports healthy fat growth. These immune cells sit near blood vessels in fat tissue and release a signal protein called BMP2 that tells fat-building cells to mature. When researchers removed KDM6B from these immune cells in mice, the cells switched into a high-energy-burning state. Fat cells became swollen, blood vessels thinned, inflammation rose, and blood sugar control worsened. The study also found that in people, higher KDM6B activity in fat-tissue immune cells was linked to better insulin sensitivity and blood sugar control. The findings are early and come mainly from mouse experiments, so they do not yet show how to change these processes in people.

Key Statistics

A 2026 study published in Nature Metabolism found that mice lacking the gene KDM6B in their immune cells developed swollen fat cells, thinner blood vessels, more inflammation, and impaired blood sugar control.

A 2026 Nature Metabolism study reported that in human fat tissue, higher KDM6B activity in immune cells was associated with better insulin sensitivity, better glucose control, and reduced inflammation.

The Quick Take

  • What they studied: The researchers asked how a gene called KDM6B affects a type of immune cell in fat tissue, and whether this helps fat tissue grow in a healthy way when a person or animal eats a high-fat diet.
  • Who participated: The study used mice fed a high-fat diet, along with mice genetically altered to lack KDM6B in their immune cells. It also looked at fat-tissue samples from people. The exact number of participants was not listed in the study summary.
  • Key finding: Mice without KDM6B in their immune cells developed swollen fat cells, thinner blood vessels, more inflammation, and poorer blood sugar control. In people, higher KDM6B activity in fat-tissue immune cells was linked to better insulin sensitivity and blood sugar control.
  • What it means for you: This research points to a possible role for KDM6B in healthy fat storage. It does not yet show that changing KDM6B levels, diet, or lifestyle will improve metabolic health in people. Anyone concerned about blood sugar or weight should talk with a healthcare provider.

The Research Details

The researchers studied how fat tissue expands when animals eat a rich diet. Fat tissue must grow in a controlled way to store extra energy safely. When it cannot, fat cells can become overstuffed, and the body can develop inflammation and problems with blood sugar.

To test the role of KDM6B, the team bred mice that lacked this gene only in their myeloid immune cells, a family of immune cells that includes macrophages. They then compared these mice with normal mice as both groups ate a high-fat diet. The team examined immune cells in fat tissue, tracked how fat cells and blood vessels changed, and measured blood sugar and inflammation.

The researchers also looked at a gene called Bmp2 to understand the mechanism. They removed Bmp2 from the same immune cells in some mice and tested whether giving the BMP2 protein directly could support healthy fat tissue remodeling. The study also included human fat-tissue samples to check whether the patterns seen in mice appeared in people.

Using genetically altered mice allowed the researchers to test cause and effect. By removing KDM6B from a specific immune cell group, they could see what happened to fat tissue and blood sugar without other factors getting in the way. Testing a signal protein directly, such as BMP2, helped show a likely step in the chain of events. Looking at human samples was an important extra step, since it showed whether the same pattern appears in people, not only in mice.

The study was published in Nature Metabolism, a respected journal that reviews research carefully before publishing. It uses several methods together, including genetic experiments, tissue analysis, and human sample data, which strengthens confidence in the results. However, the exact number of participants was not stated in the summary, and the strongest evidence comes from mice. Human data show associations rather than proof that KDM6B causes better metabolic health.

What the Results Show

The main finding is that KDM6B helps keep a specific group of immune cells, called LYVE1+ perivascular macrophages, in a state that supports fat tissue growth. These immune cells sit close to blood vessels within fat tissue. When KDM6B was missing, the immune cells shifted into a different state, labeled CLEC1A+, which the researchers describe as hypermetabolic. This means these cells appeared to burn energy at a higher rate and were less helpful for building fat tissue.

When these changes occurred, the mice showed several problems. Fat cells grew larger than normal, a condition called adipocyte hypertrophy. Blood vessels in the fat tissue became sparse, which is called vascular rarefaction. Inflammation increased, and the mice had trouble controlling their blood sugar. These results suggest that fat tissue depends on a careful balance among immune cells to expand safely.

The researchers traced part of this effect to a signal protein called BMP2. KDM6B helps keep the Bmp2 gene active by limiting a chemical mark called H3K27me3 that can switch genes off. When the immune cells lacked KDM6B, the Bmp2 gene became more silenced, and less BMP2 signaling reached the fat-building cells. Removing Bmp2 from the immune cells caused some of the same fat tissue problems, although not all of them. Giving BMP2 directly supported healthier tissue remodeling, which suggests this signal is an important part of the process.

In people, the researchers found that higher KDM6B levels in fat-tissue immune cells were associated with better insulin sensitivity, better glucose control, and lower inflammation. This matches the mouse results, but these human findings show a link, not proof that KDM6B directly causes these benefits.

The study suggests that KDM6B acts like an epigenetic switch. Epigenetic switches control which genes are turned on or off without changing the DNA sequence itself. This means the body’s immune cells may adjust their behavior based on diet and other signals, and KDM6B appears to be one control point in that process. Because the researchers saw partial rather than complete effects when they removed Bmp2 alone, other signals likely also contribute to fat tissue health.

Earlier research has shown that immune cells in fat tissue, including macrophages, play a major role in inflammation and blood sugar problems in obesity. This study adds a more detailed picture by identifying a specific macrophage group, the LYVE1+ perivascular macrophages, and a specific gene, KDM6B, that helps keep them in a fat-supportive state. It also links this process to BMP2, a signal that helps fat-building cells mature. Together, these findings add to a growing view that fat tissue health depends on the careful behavior of immune cells, not only on the fat cells themselves.

Most of the detailed experiments were done in mice, and mice do not perfectly match human biology. The human part of the study looked at associations, which means it can show that two things tend to occur together, but cannot prove that one causes the other. The summary does not state the number of people or mice in each group, which makes it harder to judge how strong the results are. Also, the study focused on a high-fat diet, so the findings may not apply to other diets or to people with different health conditions. More research will be needed to see whether these findings lead to safe and useful treatments.

The Bottom Line

At this stage, the research supports a general idea rather than a specific action: healthy fat tissue depends on a balance among immune cells, and KDM6B appears to be part of that balance. Confidence is moderate for the mouse findings, which were tested with several methods, and lower for applying them to people, where the human data show associations. No dietary or supplement change should be based on this study alone. Established steps for supporting metabolic health, such as regular physical activity, balanced meals, adequate sleep, and routine medical checkups, remain the best evidence-based choices.

People with obesity, prediabetes, or type 2 diabetes may find this research especially relevant because it looks at how fat tissue and blood sugar are connected. Researchers studying metabolism, immunology, and drug development may find the KDM6B and BMP2 pathways useful for future studies. People who are healthy and not concerned about blood sugar or fat tissue health do not need to change anything based on this research alone.

Findings from mouse studies usually take many years to reach people, and many do not reach clinical use at all. Testing a new treatment in people involves several phases of safety and effectiveness trials. Readers should not expect any new treatment or practical change based on this study in the near term. Any change in daily habits should be guided by proven strategies, and the benefits of those strategies typically appear over weeks to months.

Frequently Asked Questions

What is KDM6B and why does it matter for fat tissue?

KDM6B is a gene that helps control which other genes are turned on or off. A 2026 study in Nature Metabolism found it helps keep immune cells in fat tissue in a state that supports healthy fat growth and steady blood sugar levels.

Does the KDM6B research mean I can change my blood sugar with diet?

Not yet. The KDM6B findings come mainly from mouse experiments, and human data show associations rather than proof. Proven steps such as regular physical activity, balanced meals, and sleep remain the best-supported ways to support blood sugar.

What did the study find about the immune cells in fat tissue?

When KDM6B was missing in mice, a group of immune cells called LYVE1+ macrophages shifted into a high-energy-burning state. This shift was linked to swollen fat cells, fewer blood vessels, increased inflammation, and worse blood sugar control.

What is BMP2 and how is it connected to this research?

BMP2 is a signal protein that helps fat-building cells mature. The study found that KDM6B helps keep the Bmp2 gene active in immune cells. Losing this signal caused some of the same fat tissue problems seen in the mice.

Want to Apply This Research?

  • Track fasting blood sugar readings if you have them available through a healthcare provider, and record them weekly in the app alongside waist circumference measured once a week at the same time of day. Note any changes in energy, sleep, or hunger patterns. These measures are practical, easy to repeat, and relevant to the blood sugar and fat tissue themes in this research.
  • Use the app to set a consistent routine for meals and physical activity, such as a daily 20 to 30 minute walk after one meal. Log meals to see how the balance of protein, fiber, and healthy fats fits your goals. Small, steady habits are more useful than dramatic changes based on early research.
  • Review trends monthly rather than daily. Compare blood sugar, waist measurements, activity levels, and energy patterns over three to six months. Share the data with a healthcare provider at routine visits so they can help interpret changes and decide whether any testing or treatment is needed.

This article summarizes early research from a 2026 study that was conducted mainly in mice, with limited human data. It is for general education only and is not medical advice. Findings may change as more research is done. Please talk with a qualified healthcare provider before making changes related to blood sugar, weight, or any medical condition.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: The histone demethylase KDM6B preserves adipogenic balance by restraining hypermetabolic LYVE1+ perivascular macrophages. , Nature metabolism (2026). PubMed 43058308 | DOI
Topics
KDM6B fat tissue expansion macrophages blood sugar control insulin sensitivity BMP2 adipose tissue Nature Metabolism 2026